More...Snapshot
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market size is estimated at xxx million U
Table of Content
1 Industry Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Glucagon Like Peptide-1 (GLP-1) Ag